Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1800562
rs1800562
0.010 GeneticVariation BEFREE A diagnosis of liver cancer or cirrhosis is rare in the lifetime of individuals from this population who are homozygous for the C282Y mutation (2.5%; upper 95% confidence interval (CI) = 8%). 10673304

2000

dbSNP: rs763569821
rs763569821
0.010 GeneticVariation BEFREE However, the frequency of primary liver carcinoma (PLC) with biliary differentiation, such as cholangiocarcinoma (CC) and combined hepatocholangiocarcinoma (CHCC), in GH remains unclear We analyzed the histologic type of 20 PLCs occurring in the background of GH; all patients were homozygotic for the C282Y mutation. 11710692

2001

dbSNP: rs1330010954
rs1330010954
0.010 GeneticVariation BEFREE With RhoGAP-deficient DLC1 mutant (DLC1-K714E), we showed that the RhoGAP activity was essential for DLC1-mediated tumor suppressor function. 16204057

2005

dbSNP: rs372894000
rs372894000
0.010 GeneticVariation BEFREE With RhoGAP-deficient DLC1 mutant (DLC1-K714E), we showed that the RhoGAP activity was essential for DLC1-mediated tumor suppressor function. 16204057

2005

dbSNP: rs756966085
rs756966085
0.010 GeneticVariation BEFREE With RhoGAP-deficient DLC1 mutant (DLC1-K714E), we showed that the RhoGAP activity was essential for DLC1-mediated tumor suppressor function. 16204057

2005

dbSNP: rs28934575
rs28934575
0.010 GeneticVariation BEFREE The mutation Arg114Gly was predicted bioinformatically to affect Nogo-66 dimensional structure of Nogo-C. Our previous works also had indicated that mutant Nogo-C promoted liver cancer cell line apoptosis and resulted in molecular marker of HCC p53 gene transfer from nucleus to cytoplast. 18080785

2009

dbSNP: rs1447295
rs1447295
0.020 GeneticVariation BEFREE Associations were observed between rs16901979 and upper aerodigestive tract cancer among never-smokers and between rs1447295 and liver cancer among ever-smokers. 18990762

2008

dbSNP: rs6983267
rs6983267
0.020 GeneticVariation BEFREE We also observed a suggestive association between rs6983267 and liver cancer (ORadj, 1.51; 95% CI, 0.99-2.31). 18990762

2008

dbSNP: rs16901979
rs16901979
0.010 GeneticVariation BEFREE Associations were observed between rs16901979 and upper aerodigestive tract cancer among never-smokers and between rs1447295 and liver cancer among ever-smokers. 18990762

2008

dbSNP: rs28929474
rs28929474
0.010 GeneticVariation BEFREE According to retrospective studies, up to 25% of those with homozygous ZZ (Glu 342 to Lys) AATD suffer from liver cirrhosis and/or liver cancer in late adulthood. 21617532

2011

dbSNP: rs738409
rs738409
0.040 GeneticVariation BEFREE The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis. 22087248

2011

dbSNP: rs4444903
rs4444903
EGF
0.020 GeneticVariation BEFREE The epidermal growth factor (EGF) rs4444903 A>G polymorphism has been associated with the development of liver cancer, which commonly complicates cirrhosis of viral origin; however, whether this polymorphism might be associated with fibrosis progression in chronic viral hepatitis is unknown. 22122913

2012

dbSNP: rs20576
rs20576
0.010 GeneticVariation BEFREE To determine if gene variants in the TRAIL receptor I (DR4) gene affect the risk of hepatitis C virus (HCV)-induced liver cancer (HCC), we analysed DR4 mutations C626G (rs20575) and A683C (rs20576) in HCV-infected patients with and without HCC. 22401174

2012

dbSNP: rs738409
rs738409
0.040 GeneticVariation BEFREE These patients were followed-up and screened for the risk of HCC, and the influence of rs738409 on the occurrence of liver cancer was assessed using the Kaplan-Meier method, then according to the multivariate Cox model. 23069476

2013

dbSNP: rs3746444
rs3746444
0.010 GeneticVariation BEFREE 35, 95% CI: 1.09-1.67), and rs3746444 was associated with liver cancer in the subgroup of cancer types. 23725137

2013

dbSNP: rs3734091
rs3734091
0.010 GeneticVariation BEFREE We investigated the role of genetic polymorphisms at XRCC4 codon 247 (rs3734091, XRCC4P) and XRCC5 codon 180 (rs80309960, XRCC5P) in liver cancer (hepatocellular carcinoma) caused by aflatoxin B1 (AFB1). 23788213

2013

dbSNP: rs80309960
rs80309960
0.010 GeneticVariation BEFREE We investigated the role of genetic polymorphisms at XRCC4 codon 247 (rs3734091, XRCC4P) and XRCC5 codon 180 (rs80309960, XRCC5P) in liver cancer (hepatocellular carcinoma) caused by aflatoxin B1 (AFB1). 23788213

2013

dbSNP: rs1801131
rs1801131
0.010 GeneticVariation BEFREE Thus, Asian individuals with the homozygote genotype CC of MTHFR rs1801131 polymorphism are significantly associated with decreased risk of liver cancer. 24014085

2014

dbSNP: rs397507444
rs397507444
0.010 GeneticVariation BEFREE MTHFR rs1801131 (A1298C) polymorphism can decrease in vitro MTHFR enzyme activity and has been hypothesized to be associated with liver cancer risk. 24014085

2014

dbSNP: rs1447295
rs1447295
0.020 GeneticVariation BEFREE In a dominant model, among those with a family history of cancer, rs1447295 was positively associated with liver cancer (OR(adj) 2.80; 95% CI 1.15-6.80). 24030569

2014

dbSNP: rs6983267
rs6983267
0.020 GeneticVariation BEFREE Heterogeneity was observed (P(heterogeneity) = 0.029) with rs6983267 and liver cancer, with positive association in the dominant model among those with a family history of cancer and positive association in the recessive model among those without a family history of cancer. 24030569

2014

dbSNP: rs1801133
rs1801133
0.020 GeneticVariation BEFREE Therefore, MTHFR Ala222Val polymorphism is significantly associated with risk of hepatitis infection but not liver cancer</span>. 24155211

2014

dbSNP: rs738409
rs738409
0.040 GeneticVariation BEFREE Variation at rs738409 was not associated with significant changes in resolution rate of hepatitis C. By contrast, M/M genotype, present at higher frequencies (22.8%) in HCC patients than in patients with chronic hepatitis C (8.5%, P = 0.004) or control individuals (9.1%, P = 0.005) was associated with a 3-fold increase of liver cancer risk. 24269995

2014

dbSNP: rs230496
rs230496
0.010 GeneticVariation BEFREE After adjusted for potential confounding factors, rs28362491 ins/del or del/del genotypes were associated with higher risk of liver cancer with an adjusted OR 1.54 (95% CI 1.04 to 2.28). rs230496 AG and GG genotypes were also noted with higher risk of liver cancer with an adjusted OR 1.53 (95% CI 1.03 to 2.26). 24578542

2014

dbSNP: rs230525
rs230525
0.010 GeneticVariation BEFREE Haplotype analysis indicated that carriers of the NFKB1 GA and AA (rs230525-rs230530) haplotypes had higher risk of liver cancer under an additive model. 24578542

2014